Biologic therapy does not affect results of endoscopic balloon dilations in Crohn's disease patients

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10295553" target="_blank" >RIV/00216208:11110/15:10295553 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064165:_____/15:10295553

Výsledek na webu

<a href="http://www.prolekare.cz/linkout/51313" target="_blank" >http://www.prolekare.cz/linkout/51313</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Biologic therapy does not affect results of endoscopic balloon dilations in Crohn's disease patients

Popis výsledku v původním jazyce

Patients with Crohn's disease are at substantial risk of recurrent stenotic complications even after they have been operated on. Endoscopic balloon dilation is an acceptable alternative to surgical therapy in selected cases. Methods: We performed a retrospective analysis of results of endoscopic balloon dilations in patients with Crohn's disease treated in our center. The aim was to assess the efficacy and safety of the balloon dilation as well as the influence of bio-logic therapy and other factors onresults of dilation therapy. Results: Between May 2007 and December 2013 we performed 220 balloon dilations on 109 Crohn's disease patients. Technical success (passage through the stricture after dilation) was achieved in 77% and clinical efficacy in 75%of cases. Technical success was associated with significantly longer duration of clinical effect (10 months vs 4.5 months, p < 0.001), and lower risk of surgery (14% vs 29%; p = 0.02). Dilation of anastomotic strictures was also associat

Název v anglickém jazyce

Biologic therapy does not affect results of endoscopic balloon dilations in Crohn's disease patients

Popis výsledku anglicky

Patients with Crohn's disease are at substantial risk of recurrent stenotic complications even after they have been operated on. Endoscopic balloon dilation is an acceptable alternative to surgical therapy in selected cases. Methods: We performed a retrospective analysis of results of endoscopic balloon dilations in patients with Crohn's disease treated in our center. The aim was to assess the efficacy and safety of the balloon dilation as well as the influence of bio-logic therapy and other factors onresults of dilation therapy. Results: Between May 2007 and December 2013 we performed 220 balloon dilations on 109 Crohn's disease patients. Technical success (passage through the stricture after dilation) was achieved in 77% and clinical efficacy in 75%of cases. Technical success was associated with significantly longer duration of clinical effect (10 months vs 4.5 months, p < 0.001), and lower risk of surgery (14% vs 29%; p = 0.02). Dilation of anastomotic strictures was also associat

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FE - Ostatní obory vnitřního lékařství

OECD FORD obor

—

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Gastroenterologie a hepatologie

ISSN

1804-7874

e-ISSN

—

Svazek periodika

69

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

5

Strana od-do

33-37

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—